![](/img/cover-not-exists.png)
Bevacizumab as a potential antiâangiogenic therapy in schistosomiasis: A double edged, but adjustable weapon
Hasby Saad, Marwa A., ElâAnwar, NohaJournal:
Parasite Immunology
DOI:
10.1111/pim.12724
Date:
April, 2020
File:
PDF, 19.88 MB
2020